AbbVie Had Seen 2026 Adjusted EPS $13.76 - $13.96 >ABBV

What happened

AbbVie had previously guided to 2026 adjusted earnings per share of $13.76 to $13.96, according to the supplied report. Adjusted earnings per share means profit per share after excluding certain items.

Confirmed

Global impact / market context

This figure is a prior company outlook for 2026 profit per share, so investors can compare it with any updated guidance to judge whether expected profit is rising or falling, which can shape views on the shares.

Analyst inference

The supplied context contains only the earlier guidance range and no new forecast, so the key question is whether AbbVie reaffirms, raises, or cuts this range, since a change would alter expected profit and investor positioning.

Analyst inference

What to watch

1. AbbVie's stated 2026 adjusted earnings per share guidance is $13.76 to $13.96, which is the prior outlook to compare against any later company update. Confirmed
2. Watch whether AbbVie reaffirms this range or changes it; a raise would imply stronger expected profit per share, while a cut would imply weaker expected profit. Analyst inference
3. Watch for updated company guidance and any stated reasons, such as changes in revenue, costs, or drug performance, that explain movement in expected 2026 profit. Analyst inference

Evidence

• Original source link unavailable